Document Detail


Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting.
MedLine Citation:
PMID:  15184720     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Bupropion SR (Zyban) has been shown in randomized controlled trials to be an efficacious pharmacological aid for smoking cessation; however, recent reports have raised serious concerns about the breadth of its applicability without complications or contraindications. METHODS: We examined this issue in a well-documented medical population, i.e. veterans volunteering to participate in a smoking cessation treatment research program involving the use of bupropion SR. RESULTS: Overall, 22% of the 78 subjects who met the study criteria were appropriate for and completed the course of medication. CONCLUSIONS: Thus, bupropion SR in nicotine-dependent veterans may not be broadly applicable when conservative prescribing guidelines are carefully followed.
Authors:
Barbara S Kohlenberg; David O Antonuccio; Steven C Hayes; Elizabeth V Gifford; Melissa P Piasecki
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Psychotherapy and psychosomatics     Volume:  73     ISSN:  0033-3190     ISO Abbreviation:  Psychother Psychosom     Publication Date:    2004 Jul-Aug
Date Detail:
Created Date:  2004-06-08     Completed Date:  2004-10-05     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0024046     Medline TA:  Psychother Psychosom     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  252-4     Citation Subset:  IM    
Copyright Information:
Copyright 2004 S. Karger AG, Basel
Affiliation:
VA Sierra Nevada Health Care System, Reno, NV, USA. Barbarak@unr.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Bupropion / contraindications,  therapeutic use*
Dopamine Uptake Inhibitors / therapeutic use*
Female
Humans
Male
Middle Aged
Smoking Cessation / methods*
Tobacco Use Disorder / drug therapy*
Grant Support
ID/Acronym/Agency:
1R01DA13106-01/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Dopamine Uptake Inhibitors; 34841-39-9/Bupropion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Positive coping up- and down-regulates in vitro cytokine productions from T cells dependent on stres...
Next Document:  Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treat...